Furthermore, the medication of other diseases such as type 2 diabetes, infectious, autoimmune, or neurological disorders, and cancer is also expected to benefit from PTP1B inhibitor research [48–50]. The gene discussed is PTPN1; the disease is type 2 diabetes mellitus.